RNF168 and non-small cell lung carcinoma: Some studies have shown that RNF168 expression is decreased in LKB1-loss-driven NSCLC, which may be due to the fact that depletion of LKB1 leads to an increased RNF168-Ser60 phosphorylation level through activating the mTORC1-S6K pathway.